Skip to content

IMPORTANT NOTIFICATION: Zantac (Ranitidine) Recall

Dear Doctor, Aspen Pharmacare Australia Pty Ltd, in consultation with the Therapeutic Goods Administration (TGA), is conducting a retail level recall of Zantac (ranitidine) tablets, effervescent tablets, syrup and ampoules. The TGA has not requested that a Dear Doctor letter be sent for this retail level product recall. We are informing you as the potentially…

Read More


Aspen Pharmacare wish to advise that Di-Gesic will be discontinued effective 1 April 2018. Regrettably, Aspen has been unable to procure suitable Active Pharmaceutical Ingredient to continue manufacture and supply of Di-Gesic in Australia. The Therapeutic Goods Administration has been notified and the product has been placed on the “Medicine Shortages Information” list. Please see the attached letter for further information.

Read More
Scroll To Top